Nocebo hyperalgesia: How anxiety is turned into pain

Current Opinion in Anaesthesiology

Volumn 20, Issue 5, 2007, Pages 435-439

  Colloca, Luana ^a   Benedetti, Fabrizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Anxiety; Cholecystokinin; Nocebo; Placebo

Indexed keywords

BENZODIAZEPINE; CHLORDIAZEPOXIDE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DIAZEPAM; MORPHINE; NALOXONE; PLACEBO; PROGLUMIDE;

ANTICIPATORY ANXIETY; DRUG DOSE INCREASE; DRUG MECHANISM; HUMAN; HYPERALGESIA; NEUROBIOLOGY; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANXIETY; CHOLECYSTOKININ; HUMANS; HYPERALGESIA; PLACEBO EFFECT; RATS;

EID: 34548667203     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3282b972fb     Document Type: Review

References (53)

1. Dworkin SF, Chen AC, LeResche L, Clark DW. Cognitive reversal of expected nitrous oxide analgesia for acute pain. Anesth Analg 1983; 62:1073-1077.
2. Benedetti F, Mayberg HS, Wager TD, et al. Neurobiological mechanisms of the placebo effect. J Neurosci 2005; 25:10390-10402.
3. Colloca L, Benedetti F. Placebos and painkillers: is mind as really as matter? Nat Rev Neurosci 2005; 6:545-552.
4. Hoffman GA, Harrington A, Fields HL. Pain and the placebo: what we have learned. Perspect Biol Med 2005; 48:248-265.
5. Pacheco-Lopez G, Engler H, Niemi MB, Schedlowski M. Expectations and associations that heal: immunomodulatory placebo effects and its neurobiology. Brain Behav Immun 2006; 20:430-446. This article reviews how the brain modulates peripheral immune reactivity through mechanisms of behavioral conditioning in animal experiments and human studies.
6. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. J Neurosci 2003; 23:4315-4323.
7. Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 2005; 114:3-6.
8. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978; ii:654-657.
9. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific sub-systems. J Neurosci 1999; 19:484-494.
10. Zubieta JK, Bueller JA, Jackson LR, et al. Placebo effects mediated by endogenous opioid activity on m-opioid receptors. J Neurosci 2005; 25:7754-7762.
11. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science 2002; 295:1737-1740.
12. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303:1162-1167.
13. Price DD, Zhou Q, Moshiree B, et al. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain 2006; 7:529-535. The synergism between abnormal afferent processing and nocebo effect, which occurs in chronic abdominal pain of patients with irritable bowel syndrome, is discussed.
14. De la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001; 293:1164-1166.
15. Benedetti F, Colloca L, Torre E, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 2004; 7:587-588.
16. Benedetti F, Colloca L. Placebo-induced analgesia: methodology, neurobiology, clinical use, and ethics. Rev Analg 2004; 7:129-143.
17. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004; 3:679-684.
18. Kennedy WP. The nocebo reaction. Med World 1961; 95:203-205.
19. Kissel P, Barrucand D. Placebos et effect placebo en medicine. Paris: Masson; 1964.
20. Hahn RA. A sociocultural model of illness and healing. In: White L, Tursky B, Schwartz GE, editors. Placebo: theory, research, and mechanisms. New York: Guilford; 1985. pp. 332-350.
21. Hahn RA. The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med 1997; 26 (5Pt1):607-611.
22. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007; 147:260-271. A thorough review to present how nocebo and nocebo-related effects may affect the course of a disease and the response to a therapy.
23. Flaten MA, Simonsen T, Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999; 61:250-255.
24. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002; 287:622-627.
25. Oftedal G, Straume A, Johnsson A, Stovner LJ. Mobile phone headache: a double blind, sham-controlled provocation study. Cephalalgia 2007; 27:447-455. This double-blind, sham-controlled provocation study provides evidence that subjective symptoms such as head pain or discomfort are nocebo effects and not symptoms related to exposure to radiofrequency fields from mobile phones.
26. Price DD, Craggs J, Nicholas Verne G, et al. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007; 127:63-72. This study is important because demonstrates the neural correlates of the placebo analgesic effect in clinically relevant conditions.
27. Manchikanti L, Pampati V, Damron K. The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician 2005; 8:349-355.
28. Svedman P, Ingvar M, Gordh T. 'Anxiebo', placebo, and postoperative pain. BMC Anesthesiol 2005; 5:9.
29. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000; 85:317-332.
30. Leeuw M, Goossens ME, Linton SJ, et al. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med 2007; 30:77-94. This review presents the state of the art of the role of fear in pain severity, pain catastrophizing, attention to pain, escape/avoidance behavior, disability, disuse and vulnerability.
31. Benedetti F, Amanzio M. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog Neurobiol 1997; 52:109-125.
32. Noble F, Wank SA, Crawley JN, et al. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 1999; 51:745-781.
33. Benedetti F, Amanzio M, Casadio C, et al. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 1997; 71:135-140.
34. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26:12014-12022. This neuropharmacological study provides evidence for a CCKergic link between anxiety and hyperalgesia in humans.
35. Andre J, Zeau B, Pohl M, et al. Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies. J Neurosci 2005; 25:7896-7904.
36. Hebb ALO, Poulin J-F, Roach SP, et al. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:1225-1238.
37. Benedetti F. Cholecystokinin type-A and type-B receptors and their modulation of opioid analgesia. News Physiol Sci 1997; 12:263-268.
38. Mitchell JM, Lowe D, Fields HL. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats. Neuroscience 1998; 87:123-133.
39. Heinricher MM, McGaraughty S, Tortorici V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 2001; 85:280-286.
40. Heinricher MM, Neubert MJ. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J Neurophysiol 2004; 92:1982-1989.
41. Ploghaus A, Tracey I, Gati JS, et al. Dissociating pain from its anticipation in the human brain. Science 1999; 284:1979-1981.
42. Sawamoto N, Honda M, Okada T, et al. Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulated cortex and parietal operculum/posterior insula: an event-related functional magnetic resonance imaging study. J Neurosci 2000; 20:7438-7445.
43. Porro CA, Baraldi P, Pagnoni G, et al. Does anticipation of pain affect cortical nociceptive systems? J Neurosci 2002; 22:3206-3214.
44. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A 2005; 102:12950-12955.
45. Lorenz J, Hauck M, Paur RC, et al. Cortical correlates of false expectations during pain intensity judgments - a possible manifestation of placebo/nocebo cognitions. Brain Behav Immun 2005; 19:283-295.
46. Keltner JR, Furst A, Fan C, et al. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 2006; 26:4437-4443. This functional magnetic resonance imaging study shows how the level of expected pain intensity alters perceived pain intensity along with the activation of different brain regions.
47. Levine JD, Gordon NC, Smith R, Fields HL. Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain 1981; 10:379-389.
48. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for nonspecific activation of endogenous opioids. Pain 2001; 90:205-215.
49. Benedetti F, Maggi G, Lopiano L, et al. Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. Prevent Treat 6, 2003. http://content2.apa.org/journals/pre/6/1/1.
50. Price DD. Assessing placebo effects without placebo groups: an untapped possibility? Pain 2001; 90:201-203.
51. Willer JC, Albe-Fessard D. Electrophysiological evidence for a release of endogenous opiates in stress-induced analgesia in man. Brain Res 1980; 198:419-426.
52. Terman GW, Morgan MJ, Liebeskind JC. Opioid and nonopioid stress analgesia from cold water swim: importance of stress severity. Brain Res 1986; 372:167-171.
53. Flor H, Grusser SM. Conditioned stress-induced analgesia in humans. Eur J Pain 1999; 3:317-324.